CMMB Stock Analysis: Buy, Sell, or Hold?
CMMB - Chemomab Therapeutics Ltd. American Depositary Share
$1.42
0.06 (4.41%)
▲
5d:
-5.33%
30d:
-8.97%
90d:
-11.8%
HOLD
LOW Confidence
Analysis Updated: Jul 27, 2026 12:00 AM ET
Earnings: Aug 13, 2026
15d
Get Alerted When CMMB Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: CMMB shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: CMMB shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: CMMB is currently trading at $1.42, which is considered slightly low relative to its 30-day fair value range of $1.35 to $2.01.
Technical Outlook: Technically, CMMB is showing sideways momentum. Immediate support is located at $1.36, while resistance sits at $1.72. The stock is showing strong short-term momentum, up 4.4% recently.
Market Sentiment: CMMB has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $5.00 (+252.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, CMMB is showing sideways momentum. Immediate support is located at $1.36, while resistance sits at $1.72. The stock is showing strong short-term momentum, up 4.4% recently.
Market Sentiment: CMMB has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $5.00 (+252.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$1.35 -
$2.01
Company Quality Score
41/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
63.2%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+4.4%)
- BULLISH: Trading 252.1% below Wall St target ($5.00)
- CAUTION: Recommendation downgraded due to -5.3% 5-day decline
Trading Range Analysis
30-Day Trading Range
$1.35 -
$2.01
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$1.36
Resistance Level
$1.72
Current Trend
Sideways
Technical data as of
Jul 27, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-47.33
Wall Street Target
$5.00
(+252.1%)
Share & Embed Analysis
Last updated: July 28, 2026 3:18 AM ET
Data refreshes hourly during market hours. Next update: 4:18 AM
Data refreshes hourly during market hours. Next update: 4:18 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CMMB showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 49 HOLD |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$86 | 59 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$555 | 54 HOLD |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$819 | 56 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$196 | 46 HOLD |
